Pioglitazone Terminated Phase 4 Trials for Hepatitis C Viral Infection / Liver Diseases / Steatosis / Human Immunodeficiency Virus (HIV) Infections / Fatty Liver Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00742326Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections